Replimune Group Earnings
NASDAQ: REPLHealthcareBiotechnologyUSD
13.20-0.05 (-0.38%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.70
Replimune Group earnings summary
Replimune Group is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.70.
Summary generated from market data by MetaCap's automated system. Methodology